scholarly journals Initial (6-Month) Results of Three-Times-Weekly Azithromycin in Treatment Regimens for Mycobacterium avium Complex Lung Disease in Human Immunodeficiency Virus-Negative Patients

1998 ◽  
Vol 178 (1) ◽  
pp. 121-126 ◽  
Author(s):  
D. E. Griffith ◽  
B. A. Brown ◽  
D. T. Murphy ◽  
W. M. Girard ◽  
L. Couch ◽  
...  
Keyword(s):  
Human Immunodeficiency Virus ◽  
Lung Disease ◽  
Mycobacterium Avium ◽  
Mycobacterium Avium Complex ◽  
Treatment Regimens ◽  
Immunodeficiency Virus

A 71-year-old man with recurrent pulmonary mycobacterial avium complex infections and lymphopenia

2020 ◽  
Vol 41 (1) ◽  
pp. 66-69 ◽  
Author(s):  
Taha Al-Shaikhly ◽  
Frederick S. Buckner ◽  
Matthew C. Altman ◽  
Hans D. Ochs ◽  
Andrew G. Ayars
Keyword(s):  
Human Immunodeficiency Virus ◽  
Mycobacterium Avium ◽  
Mycobacterium Avium Complex ◽  
Opportunistic Infections ◽  
Clinical Course ◽  
Critical Role ◽  
T Cell Immunity ◽  
Cell Immunity ◽  
Immunodeficiency Disorder ◽  
Immunodeficiency Virus

Mycobacterium avium complex (MAC) infections, generally viewed as opportunistic infections, often trigger an evaluation for an underlying immunodeficiency disorder. However, MAC infections can occur in patients who presumably are immunocompetent, particularly in those with an underlying structural lung disease. T-cell immunity plays a critical role in controlling MAC infection. We presented a case of lymphopenia, which complicated the clinical course of a pulmonary MAC infection in a patient who was negative for human immunodeficiency virus.

Sign in / Sign up

Export Citation Format

Share Document